Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $415.34 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $184.34 | 2 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $87.43 | 1 | $0 (2019) |
| Allergan Inc. | $38.61 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $26.86 | 1 | $0 (2023) |
| Lilly USA, LLC | $19.29 | 1 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $16.04 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $15.25 | 1 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $14.48 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $13.04 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.73 | 2 | E.R. Squibb & Sons, L.L.C. ($15.25) |
| 2023 | $26.86 | 1 | Regeneron Healthcare Solutions, Inc. ($26.86) |
| 2021 | $160.33 | 3 | Novo Nordisk Inc ($125.00) |
| 2019 | $100.47 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($87.43) |
| 2018 | $59.34 | 1 | Novo Nordisk Inc ($59.34) |
| 2017 | $38.61 | 1 | Allergan Inc. ($38.61) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 04/04/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Ophthalmology | ||||||
| 04/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/16/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 06/30/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 03/09/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Ocular | ||||||
| 11/04/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/06/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $87.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $59.34 | General |
| Category: Diabetes | ||||||
| 10/19/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $38.61 | General |
| Category: DRY EYE | ||||||
About Dr. Christina Johnson, M.D
Dr. Christina Johnson, M.D is a Ophthalmology healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1740695667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christina Johnson, M.D has received a total of $415.34 in payments from pharmaceutical and medical device companies, with $29.73 received in 2024. These payments were reported across 10 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($415.34).
Practice Information
- Specialty Ophthalmology
- Location Weslaco, TX
- Active Since 06/30/2014
- Last Updated 06/30/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1740695667
Products in Payments
- RYBELSUS (Drug) $125.00
- VYZULTA (Drug) $87.43
- Ozempic (Drug) $59.34
- RESTASIS (Drug) $38.61
- XIIDRA (Drug) $27.52
- EYLEA (Biological) $26.86
- TRULICITY (Drug) $19.29
- INVELTYS (Drug) $16.04
- CAMZYOS (Drug) $15.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.